Related Experiment Videos
[Agranulocytosis caused by clozapine]
R C Kok1, W A Veenhoven, M J Hoogschagen
1Algemeen Pschiatrisch Centrum Amsterdam, Santpoort-Zuid.
Nederlands Tijdschrift Voor Geneeskunde
|April 18, 1992
Summary
Clozapine can cause agranulocytosis, a dangerous drop in white blood cells, in psychotic patients. Regular blood monitoring is crucial, especially for patients unable to report symptoms, to detect infections early.
Area of Science:
- Pharmacology
- Hematology
- Psychiatry
Context:
- Clozapine is an atypical antipsychotic used for treatment-resistant schizophrenia.
- Agranulocytosis is a rare but life-threatening adverse effect of clozapine therapy.
- Psychotic patients may be unable to communicate early symptoms of infection.
Purpose:
- To highlight the risk of clozapine-induced agranulocytosis.
- To emphasize the critical role of medical personnel in monitoring patients.
- To outline essential monitoring protocols for clozapine treatment.
Summary:
- This article details a case of clozapine-induced agranulocytosis in a psychotic patient.
- It stresses the importance of clear instructions for medical staff, particularly for patients with impaired communication.
- Recommended monitoring includes weekly leukocyte counts for the first 18 weeks, then monthly, with immediate counts upon suspected infection.
Impact:
- Ensures timely detection and management of clozapine-induced agranulocytosis.
- Improves patient safety during clozapine therapy.
- Provides a clear guideline for healthcare professionals managing patients on clozapine.